| 151235746 | CV1319159 | single nucleotide variant | NC_012920.1(MT-ND3):m.10172G>A | Mitochondrial disease [RCV001796951] | likely benign | MT | 10172 | 10172 | Human | 1 | name |
| 9586933 | CV165636 | single nucleotide variant | NC_012920.1(MT-ND3):m.10254G>A | Leigh syndrome [RCV000144012]|Mitochondrial disease [RCV005251082] | pathogenic|likely pathogenic|not provided | MT | 10254 | 10254 | Human | 2 | name |
| 9589314 | CV166157 | single nucleotide variant | NC_012920.1(MT-ND3):m.10134C>A | Leigh syndrome [RCV000144458]|Mitochondrial disease [RCV003985280] | pathogenic|uncertain significance | MT | 10134 | 10134 | Human | 2 | name |
| 153350056 | CV1694110 | single nucleotide variant | NC_012920.1(MT-ND3):m.10161A>T | Mitochondrial disease [RCV002276493] | uncertain significance | MT | 10161 | 10161 | Human | 1 | name |
| 11350975 | CV237143 | single nucleotide variant | NC_012920.1(MT-ND3):m.10335T>C | not provided [RCV000224727] | likely benign | MT | 10335 | 10335 | Human | | name |
| 11350683 | CV237308 | single nucleotide variant | NC_012920.1(MT-ND3):m.10084T>C | Leigh syndrome [RCV000854616]|not provided [RCV000224206] | benign|likely benign | MT | 10084 | 10084 | Human | 1 | name |
| 11350947 | CV237461 | single nucleotide variant | NC_012920.1(MT-ND3):m.10321T>C | Leigh syndrome [RCV000854636]|not provided [RCV000224675] | benign|likely benign | MT | 10321 | 10321 | Human | 1 | name |
| 8555047 | CV24751 | single nucleotide variant | NC_012920.1(MT-ND3):m.10191T>C | Leigh syndrome [RCV000144010]|Mitochondrial complex 1 deficiency, mitochondrial type 1 [RCV000010358]|Mitochondrial complex I deficiency [RCV001542636]|Mitochondrial disease [RCV002291212] | pathogenic|likely pathogenic | MT | 10191 | 10191 | Human | 4 | name |
| 8555048 | CV24752 | single nucleotide variant | NC_012920.1(MT-ND3):m.10398A>G | Leigh syndrome [RCV000854647]|Parkinson disease, resistance to [RCV000010359]|not provided [RCV004713167] | pathogenic|benign|protective | MT | 10398 | 10398 | Human | 2 | name |
| 8555049 | CV24753 | single nucleotide variant | NC_012920.1(MT-ND3):m.10158T>C | Leigh syndrome [RCV000144009]|Mitochondrial complex 1 deficiency, mitochondrial type 1 [RCV000010360]|Mitochondrial disease [RCV001796716]|not provided [RCV000224598] | pathogenic | MT | 10158 | 10158 | Human | 3 | name |
| 8555050 | CV24754 | single nucleotide variant | NC_012920.1(MT-ND3):m.10197G>A | Leber optic atrophy and dystonia [RCV000010363]|Leigh syndrome [RCV000144011]|Mitochondrial DNA-Associated Leigh Syndrome and NARP [RCV002247309]|Mitochondrial complex 1 deficiency, mitochondrial type 1 [RCV000010362]|Mitochondrial disease [RCV002291213]|Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy [RCV004767000]|See cases [RCV004017234]|not provided [RCV000507278]|not specified [RCV002285008] | pathogenic|likely pathogenic | MT | 10197 | 10197 | Human | 6 | name |
| 407453660 | CV3414880 | single nucleotide variant | NC_012920.1(MT-ND3):m.10372A>G | sensorimotor axonal polyneuropathy [RCV004597216] | not provided | MT | 10372 | 10372 | Human | | name |
| 598160466 | CV3897281 | single nucleotide variant | NC_012920.1(MT-ND3):m.10176G>A | MELAS syndrome [RCV005368251] | likely pathogenic | MT | 10176 | 10176 | Human | 1 | name |
| 15016333 | CV680149 | single nucleotide variant | NC_012920.1(MT-ND3):m.10083A>G | Leigh syndrome [RCV000854615] | likely benign | MT | 10083 | 10083 | Human | 1 | name |
| 15016334 | CV680150 | single nucleotide variant | NC_012920.1(MT-ND3):m.10086A>G | Leigh syndrome [RCV000854617]|not provided [RCV004714128] | benign | MT | 10086 | 10086 | Human | 1 | name |
| 15016335 | CV680151 | single nucleotide variant | NC_012920.1(MT-ND3):m.10098G>T | Leigh syndrome [RCV000854618] | likely benign | MT | 10098 | 10098 | Human | 1 | name |
| 15016336 | CV680152 | single nucleotide variant | NC_012920.1(MT-ND3):m.10110A>G | Leigh syndrome [RCV000854619] | uncertain significance | MT | 10110 | 10110 | Human | 1 | name |
| 15016337 | CV680153 | single nucleotide variant | NC_012920.1(MT-ND3):m.10111T>C | Leigh syndrome [RCV000854620] | uncertain significance | MT | 10111 | 10111 | Human | 1 | name |
| 15016338 | CV680154 | single nucleotide variant | NC_012920.1(MT-ND3):m.10113A>G | Leigh syndrome [RCV000854621] | likely benign | MT | 10113 | 10113 | Human | 1 | name |
| 15016339 | CV680155 | single nucleotide variant | NC_012920.1(MT-ND3):m.10143G>A | Leigh syndrome [RCV000854622]|not provided [RCV004714129] | benign | MT | 10143 | 10143 | Human | 1 | name |
| 15016340 | CV680156 | single nucleotide variant | NC_012920.1(MT-ND3):m.10146T>C | Leigh syndrome [RCV000854623] | uncertain significance | MT | 10146 | 10146 | Human | 1 | name |
| 15016341 | CV680157 | single nucleotide variant | NC_012920.1(MT-ND3):m.10158T>A | Leigh syndrome [RCV000854624] | uncertain significance | MT | 10158 | 10158 | Human | 1 | name |
| 15016342 | CV680158 | single nucleotide variant | NC_012920.1(MT-ND3):m.10159C>A | Leigh syndrome [RCV000854625] | uncertain significance | MT | 10159 | 10159 | Human | 1 | name |
| 15016343 | CV680159 | single nucleotide variant | NC_012920.1(MT-ND3):m.10188A>G | Leigh syndrome [RCV000854626] | likely benign | MT | 10188 | 10188 | Human | 1 | name |
| 15016344 | CV680160 | single nucleotide variant | NC_012920.1(MT-ND3):m.10192C>A | Leigh syndrome [RCV000854627] | likely benign | MT | 10192 | 10192 | Human | 1 | name |
| 15016345 | CV680161 | single nucleotide variant | NC_012920.1(MT-ND3):m.10192C>T | Leigh syndrome [RCV000854628] | benign | MT | 10192 | 10192 | Human | 1 | name |
| 15016346 | CV680162 | single nucleotide variant | NC_012920.1(MT-ND3):m.10203G>A | Leigh syndrome [RCV000854629] | benign | MT | 10203 | 10203 | Human | 1 | name |
| 15016347 | CV680163 | single nucleotide variant | NC_012920.1(MT-ND3):m.10225T>C | Leigh syndrome [RCV000854630] | uncertain significance | MT | 10225 | 10225 | Human | 1 | name |
| 15016348 | CV680164 | single nucleotide variant | NC_012920.1(MT-ND3):m.10236A>G | Leigh syndrome [RCV000854631] | uncertain significance | MT | 10236 | 10236 | Human | 1 | name |
| 15016349 | CV680165 | single nucleotide variant | NC_012920.1(MT-ND3):m.10266G>A | Leigh syndrome [RCV000854633] | uncertain significance | MT | 10266 | 10266 | Human | 1 | name |
| 15016350 | CV680166 | single nucleotide variant | NC_012920.1(MT-ND3):m.10269C>A | Leigh syndrome [RCV000854634] | uncertain significance | MT | 10269 | 10269 | Human | 1 | name |
| 15016351 | CV680167 | single nucleotide variant | NC_012920.1(MT-ND3):m.10320G>A | Leigh syndrome [RCV000854635] | benign | MT | 10320 | 10320 | Human | 1 | name |
| 15016352 | CV680168 | single nucleotide variant | NC_012920.1(MT-ND3):m.10324T>C | Leigh syndrome [RCV000854637] | benign | MT | 10324 | 10324 | Human | 1 | name |
| 15016353 | CV680169 | single nucleotide variant | NC_012920.1(MT-ND3):m.10326T>A | Leigh syndrome [RCV000854638] | likely benign | MT | 10326 | 10326 | Human | 1 | name |
| 15016354 | CV680170 | single nucleotide variant | NC_012920.1(MT-ND3):m.10326T>C | Leigh syndrome [RCV000854639] | uncertain significance | MT | 10326 | 10326 | Human | 1 | name |
| 15016355 | CV680171 | single nucleotide variant | NC_012920.1(MT-ND3):m.10329T>C | Leigh syndrome [RCV000854640] | uncertain significance | MT | 10329 | 10329 | Human | 1 | name |
| 15016356 | CV680172 | single nucleotide variant | NC_012920.1(MT-ND3):m.10345T>C | Leigh syndrome [RCV000854641] | benign | MT | 10345 | 10345 | Human | 1 | name |
| 15016357 | CV680173 | single nucleotide variant | NC_012920.1(MT-ND3):m.10348T>C | Leigh syndrome [RCV000854642] | uncertain significance | MT | 10348 | 10348 | Human | 1 | name |
| 15016358 | CV680174 | single nucleotide variant | NC_012920.1(MT-ND3):m.10353G>A | Leigh syndrome [RCV000854643] | uncertain significance | MT | 10353 | 10353 | Human | 1 | name |
| 15016359 | CV680175 | single nucleotide variant | NC_012920.1(MT-ND3):m.10365G>A | Leigh syndrome [RCV000854644] | benign | MT | 10365 | 10365 | Human | 1 | name |
| 15016360 | CV680176 | single nucleotide variant | NC_012920.1(MT-ND3):m.10366C>T | Leigh syndrome [RCV000854645] | uncertain significance | MT | 10366 | 10366 | Human | 1 | name |
| 15016361 | CV680177 | single nucleotide variant | NC_012920.1(MT-ND3):m.10371G>A | Leigh syndrome [RCV000854646] | uncertain significance | MT | 10371 | 10371 | Human | 1 | name |
| 15016362 | CV680178 | single nucleotide variant | NC_012920.1(MT-ND3):m.10398A>T | Leigh syndrome [RCV000854648] | likely benign | MT | 10398 | 10398 | Human | 1 | name |
| 15016363 | CV680179 | single nucleotide variant | NC_012920.1(MT-ND3):m.10399C>T | Leigh syndrome [RCV000854649] | uncertain significance | MT | 10399 | 10399 | Human | 1 | name |
| 15016364 | CV680180 | single nucleotide variant | NC_012920.1(MT-ND3):m.10401G>A | Leigh syndrome [RCV000854650] | uncertain significance | MT | 10401 | 10401 | Human | 1 | name |
| 8555183 | CV76416 | single nucleotide variant | NC_012920.1(MT-ND3):m.10237T>C | Leber optic atrophy [RCV000055695]|Leigh syndrome [RCV000854632] | pathogenic|benign|not provided | MT | 10237 | 10237 | Human | 3 | name |